Sanofi bulks up cancer offering with Synthorx buy
The French drugmaker is spending around $2.5 billion on the deal
Read More
Tag: synthorin
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
